Protalix Biotherapeutics Inc (NYSE American:PLX)

0.43
Delayed Data
As of May 18
 +0.01 / +2.38%
Today’s Change
0.39
Today|||52-Week Range
0.99
-34.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues6.4M7.5M2.5M4.6M
 
 
 
 
 
Cost of Goods Sold5.0M5.6M1.1M2.5M
 
 
 
 
 
Depreciation And Amortization494.0K483.0K451.0K430.0K
 
 
 
 
 
 
Operating ExpensesGross Income835.0K1.5M915.0K1.6M
 
 
 
 
 
General Expenses12.1M10.0M13.1M9.8M
 
 
 
 
 
Research And Development9.3M7.1M9.8M7.3M
 
 
 
 
 
Total Operating Expenses17.6M16.0M14.7M12.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-8.5M-12.2M-8.2M
 
 
 
 
 
Extraordinary Credit14.3M0.000.000.00
 
 
Extraordinary Charge0.00-1.3M-25.0K--
 
 
 
Interest Expense On Debt3.0M2.4M2.2M2.2M
 
 
 
 
 
Other Expenses478.0K729.0K791.0K843.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income450.0K-11.4M-15.1M-9.4M
 
 
 
 
 
Net Income450.0K-11.4M-15.1M-9.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS127.5M132.5M137.6M145.3M
 
 
 
 
 
Shares To Calculate EPS Diluted192.6M132.5M137.6M145.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.09-$0.11-$0.06
 
 
 
 
 
EPS Diluted-$0.06-$0.09-$0.11-$0.06